Purpose-3-Demethylubiquinone Q 2 (1) was isolated from the ascidian Aplidium glabrum. The cancer preventive properties and the structure-activity relationship for 3-demethylubiquinone Q2 (1) and 12 of its synthetic analogues (3-14) are reported.Methods-Compounds 3-14, having one or several di-or triprenyl substitutions and quinone moieties with methoxyls in different positions, were synthesized. The cancer preventive properties of compounds 1 and 3-14 were tested in JB6 Cl41 mouse skin cells, using a variety of assessments, including the MTS assay, flow cytometry, and soft agar assay. Statistical nonparametric methods were used to confirm statistical significance.Results-All quinones tested were shown to inhibit JB6 Cl41 cell transformation, to induce apoptosis, AP-1 and NF-κB activity, and to inhibit p53 activity. The most promising effects were indicated for compounds containing two isoprene units in a side chain and a methoxyl group at the para-position to a polyprenyl substitution.Conclusions-Quinones 1 and 3-14 demonstrated cancer preventive activity in JB6 Cl41 cells, which may be attributed to the induction of p53-independent apoptosis. These activities depended on the length of side chains and on the positions of the methoxyl groups in the quinone part of the molecule.Keywords marine prenylated quinones; cancer prevention; apoptosis; nuclear factor; structure-activity relationship ABBREVIATIONS 3-demethylubiquinone Q2. 2,3-dimethoxy-5-(3′,7′-dimethyl-octa-2′(E),6′-dienyl)- [1,4] benzoquinone (1); EGF, epidermal growth factor; TPA, 12-O-tetradecanoyl-phorbol-13-acetate; FBS, fetal bovine serum; MEM, minimum essential medium